A brilliant breakthrough in OI type V

S Lazarus, P Moffatt, E. L. Duncan, G. P Thomas

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    Interferon-induced transmembrane protein 5 or bone-restricted ifitm-like gene (Bril) was first identified as a bone gene in 2008, although no in vivo role was identified at that time. A role in human bone has now been demonstrated with a number of recent studies identifying a single point mutation in Bril as the causative mutation in osteogenesis imperfecta type V (OI type V). Such a discovery suggests a key role for Bril in skeletal regulation, and the completely novel nature of the gene raises the possibility of a new regulatory pathway in bone. Furthermore, the phenotype of OI type V has unique and quite divergent features compared with other forms of OI involving defects in collagen biology. Currently it appears that the underlying genetic defect in OI type V may be unrelated to collagen regulation, which also raises interesting questions about the classification of this form of OI. This review will discuss current knowledge of OI type V, the function of Bril, and the implications of this recent discovery.
    Original languageEnglish
    Pages (from-to)399-405
    Number of pages7
    JournalOsteoporosis International
    Volume25
    Issue number2
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'A brilliant breakthrough in OI type V'. Together they form a unique fingerprint.

  • Cite this